Investor · Calabasas, CA

null Platinum Group

Open null in the network graph →

Filings

9

SEC Form D

Connections

52

co-filers

Capital

$3.8M

across filings

Active

Aug 2017

to Jan 2021

Most-connected co-filers (52)

Michael D. Feinglass · CHICAGO, IL4 shared Jessica A. Benish · Cottage Grove, WI4 shared Alexander A. Kodatsky · Toronto, Ontario, Canada4 shared William F. Souder · CHICAGO, IL4 shared Adam D'Augelli · New York, NY4 shared Secondary Rcp Advisors 3, LLC · Chicago, IL4 shared Steven J. Bersell · Milwaukee, WI4 shared Robert C. Williams · Toronto, Ontario, Canada4 shared Francois Kress · Brooklyn, NY4 shared Louis W. Moelchert · Richmond, VA4 shared Joseph Pendon · San Antonio, TX4 shared Joseph T. Phoenix · Boston, MA4 shared Uri Birenberg · Central District, L34 shared Andrew R. Nelson · Chicago, IL4 shared Thomas P. Danis, Jr · Chicago, IL4 shared Jennifer L. Mckee · Springfield, PA4 shared Andrew Vitus · SAN FRANCISCO, CA4 shared Kamaldeep C. Singh Grewal · Toronto, Ontario, Canada4 shared Jeff P. Gehl · Santa Monica, CA4 shared Robert Nelsen · Brooklyn, NY4 shared Mohamad Hussein · Melbourne Beach, FL4 shared James N. Arrol · Luxembourg, Luxembourg4 shared Eric M. Siegal · CHICAGO, IL3 shared Corporate Director Gpe Viii Investments Manager Limited · Nicosia, G43 shared

Recent filings (9)

Emerging Ventures Fund I, LPJan 2021 · 7 co-filers$2.8M Emerging Ventures Fund I, LPMar 2020 · 7 co-filers$1.0M Amylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0M RCPDirect III, LPApr 2019 · 22 co-filers$385.0M RCPDirect III, LPJan 2019 · 22 co-filers$350.0M Amylyx Pharmaceuticals, Inc.Nov 2018 · 23 co-filers$13.0M RCPDirect III, LPNov 2018 · 22 co-filers$350.0M RCPDirect III, LPOct 2018 · 22 co-filers$350.0M Amylyx Pharmaceuticals, Inc.Aug 2017 · 15 co-filers$2.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See null in the interactive graph →